FindTrial
Sign In

Clinical Observation on the Treatment of Senile Insomnia of Heart-Kidney Disharmony Type by Combined Acupuncture at "Umbilical Four-Side Points" Through Regulating the Activity of the HPA Axis

Clinical Observation on the Treatment of Senile Insomnia of Heart-Kidney Disharmony Type by Combined Acupuncture at "Umbilical Four-Side Points" Through Regulating the Activity of the HPA Axis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000480
Enrollment
Unknown
Registered
2026-03-09
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

control group:Routine acupuncture at Shenmen (HT7), Taixi (KI3), Baihui (GV20), Zhaohai (KI6) and Fuliu (KI7)
Treatment Group:On the basis of the treatment for the control group, acupuncture at the Umbilical Four-Side Points as the main acupoints was additionally administered.

Sponsors

Zhengzhou Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria for insomnia specified in Chinese Classification of Mental Disorders (CCMD-3); 2) Meet the diagnostic criteria for insomnia of Heart-Kidney Disharmony type in traditional Chinese medicine, and be aged between 65 and 75 years old; 3) No communication or cognitive impairments; 4) Voluntarily accept random grouping and sign the informed consent form; 5) No dependence on any psychotropic drugs; if occasionally taking relevant drugs, the patient must have discontinued the medication for more than 1 week before the start of this clinical study; 6) Patients who agree to receive acupuncture treatment.

Exclusion criteria

Exclusion criteria: 1) Patients with complicated severe cardiac insufficiency, renal insufficiency, coagulation disorders, or respiratory failure; 2) Patients with severe schizophrenia, cognitive impairments, or those unable to correctly express their chief complaints; 3) Patients currently participating in other clinical trials; 4) Patients with extreme anxiety about acupuncture or a history of acupuncture syncope; 5) Secondary insomnia caused by relevant physical symptoms such as severe cancer pain or dyspnea due to airway obstruction by tumors.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index(PSQI);Athens Insomnia Scale(AIS);—

Secondary

MeasureTime frame
Cortisol(COR);Adrenocorticotropic Hormone(ACTH);;Norepinephrine(NE);5-hydroxytryptamine(5-HT);Dopamine(DA);—

Countries

China

Contacts

Public ContactLizhenhua

Zhengzhou Hospital of Traditional Chinese Medicine Affiliated to Henan University of Chinese Medicine

604371961@qq.com18768883623

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026